The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5.

about

Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.

P2860

Q55371625-D6C39133-BDC0-4F70-A46D-1493FC3723E6

P2860

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5.

Item

http://www.wikidata.org/entity/Q41387467

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The proteasome deubiquitinase ...... tosis through stabilizing DR5.

@en

type

Item

label

The proteasome deubiquitinase ...... tosis through stabilizing DR5.

@en

prefLabel

The proteasome deubiquitinase ...... tosis through stabilizing DR5.

@en

P1476

The proteasome deubiquitinase ...... tosis through stabilizing DR5.

@en

P2093

Jiusheng Deng

http://www.w3.org/2001/XMLSchema#string

Liang Deng

http://www.w3.org/2001/XMLSchema#string

Shi-Yong Sun

http://www.w3.org/2001/XMLSchema#string

You-Take Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling

Getting TRAIL back on track for cancer therapy

Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells

The Janus Face of Death Receptor Signaling during Tumor Immunoediting

Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5

A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

Aberrant DR5 transport through disruption of lysosomal function suggests a novel mechanism for receptor activation

Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15

P2888

s41598-017-08424-w

P304

8027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-08424-W

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28808321

http://www.w3.org/2001/XMLSchema#string

P932

5556018

http://www.w3.org/2001/XMLSchema#string

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5.

about

P2860

P2860

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932